Challenges and opportunities for ginseng-based medicines in treating cardiac fibrosis from mechanistic insights to clinical translationOA
Challenges and opportunities for ginseng-based medicines in treating cardiac fibrosis from mechanistic insights to clinical translation
Mengtao Zhi;Ao Wang;Hailian Quan;Lan Hong
Department of Physiology and Pathophysiology,School of Medicine,Yanbian University,Yanji 133002,ChinaPharmaceutical Experiment Teaching Center,College of Pharmacy,Yanbian University,Yanji 133002,ChinaDepartment of Physiology and Pathophysiology,School of Medicine,Yanbian University,Yanji 133002,ChinaDepartment of Physiology and Pathophysiology,School of Medicine,Yanbian University,Yanji 133002,China
cardiacfibrosisextracellular matrix remodelingginsengmyofibroblast activationNrf2/Keap1 axisquality markersROS-responsive nanoparticlesTGF-β signaling
cardiacfibrosisextracellular matrix remodelingginsengmyofibroblast activationNrf2/Keap1 axisquality markersROS-responsive nanoparticlesTGF-β signaling
《中草药（英文版）》 2026 (3)
555-570,16
This work was financially supported by the National Natural Science Foundation of China(No.82360065).
评论